BSVN
Bank7 Corp.
BSVN trails on the overall score without a compensating advantage in the available component scores.
JPM
JPMorgan Chase & Co.
JPM has the edge over BSVN overall, supported by stronger fundamentals and stronger modeled upside.
BSVN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
BSVN's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like BSVN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BSVN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $31.80 | -46% |
| Fair | 9.3x | $40.06 | -32% |
| Forward | 11x | $58.65 | — |
| Expensive | 12x | $50.00 | -15% |
| Current | 14x | $58.65 | — |
Historical ranges are pointers, not guarantees.
BSVN's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over BSVN in the historical PE scenario, which offers more potential upside but is not a forecast.
BSVN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BSVN, but weaker profitability. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
BSVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.28 | +23% |
| Q3 2026 | $4.31 | -4.9% |
| Q2 2026 | $4.38 | -5.6% |
| Q1 2026 | $4.67 | -0.8% |
| Q4 2025 | $4.50 | -7% |
| Q3 2025 | $4.53 | +20% |
| Q2 2025 | $4.64 | +36% |
| Q1 2025 | $4.71 | +46% |
| Q4 2024 | $4.84 | +59% |
BSVN earned $4.31 per share over the past year, down 4.9% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over BSVN on earnings, with more consistent year-over-year improvement.
BSVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.4M | -7.4% |
| Q2 2026 | $22.9M | -6.3% |
| Q1 2026 | $26.2M | +16% |
| Q4 2025 | $24.1M | -0.1% |
| Q3 2025 | $25.2M | +1.4% |
| Q2 2025 | $24.4M | +0.2% |
| Q1 2025 | $22.6M | -5.9% |
| Q4 2024 | $24.1M | -14% |
BSVN's revenue fell from its 2023 peak and has held roughly level since: $23M last quarter, down 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | +2 points |
| Q2 2026 | 48% | -12 points |
| Q1 2026 | 60% | -0.2 points |
| Q4 2025 | 59% | -2.3 points |
| Q3 2025 | 56% | -6 points |
| Q2 2025 | 60% | -2.4 points |
| Q1 2025 | 61% | -1.3 points |
| Q4 2024 | 61% | +55 points |
BSVN has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over BSVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
BSVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.4M | -12% |
| Q2 2026 | $5.4M | -38% |
| Q1 2026 | $14.2M | +73% |
| Q4 2025 | $8M | -32% |
| Q3 2025 | $16.4M | +29% |
| Q2 2025 | $8.8M | +35% |
| Q1 2025 | $8.2M | -59% |
| Q4 2024 | $11.8M | -26% |
BSVN has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
BSVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +35.8K shares |
| 1 year | +0.4% | +42.1K shares |
| 3 years | +4% | +366K shares |
| 5 years | +5.9% | +535K shares |
| Available history | -5% | -507K shares |
BSVN has 10M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $141,000 |
| Q2 2026 | — |
| Q1 2026 | $1.2M |
| Q4 2025 | $251,000 |
| Q3 2025 | $9,000 |
| Q2 2025 | $2,000 |
| Q1 2025 | $1M |
| Q4 2024 | $241,000 |
BSVN spent $2M buying back its own shares over the past year, up 24% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over BSVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BSVN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.0x | Net Cash |
| Q2 2026 | -3.9x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -4.2x | Net Cash |
| Q3 2025 | -4.1x | Net Cash |
| Q2 2025 | -3.7x | Net Cash |
| Q1 2025 | -4.0x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
BSVN has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
BSVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.1 | Overbought |
| Stochastic | 85.8 | Overbought |
BSVN's weekly RSI is 70 (overbought) and its Stochastic is 86 (overbought).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BSVN PE vs Financial Services Sector
| Metric | BSVN | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 4.5% above |
| PE % | 96 | 63 | 33 pts above |
BSVN has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
BSVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $57.3 | 2.3% above |
| 20 week MA | $54.2 | 8.3% above |
| 50 week MA | $47.6 | 23% above |
| 100 week MA | $45.0 | 30% above |
| 200 week MA | $37.2 | 58% above |
BSVN has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
BSVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.0 | $13.9 | -27% |
| 2021 | $13.9 | $22.6 | +63% |
| 2022 | $22.6 | $25.7 | +14% |
| 2023 | $25.7 | $27.4 | +6.3% |
| 2024 | $27.4 | $45.8 | +67% |
| 2025 | $45.8 | $41.1 | -10% |
| 2026 YTD | $41.1 | $58.7 | +43% |
BSVN has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.